Sa1961 ONE YEAR OF DUODENAL-JEJUNAL BYPASS LINER THERAPY (ENDOBARRIER ®) LEADS TO SIGNIFICANT CHANGES IN LIVER BIOCHEMISTRY ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE

Bariatric surgery has been shown to significantly improve both liver biochemistry and histology leading to improvements in Non Alcoholic Fatty Liver Disease (NAFLD). The Endobarrier is an endoscopically implanted duodenal jejunal bypass liner (DJBL) designed to mimic the effects of bariatric surgery leading to significant weight loss and improvements in glycaemic control. The purpose of this sub-study was to evaluate the effects of DJBL therapy on liver plasma parameters of NAFLD in obese patients with Type 2 Diabetes (T2DM).

Source: Gastrointestinal Endoscopy - May 31, 2020 Category: Gastroenterology Authors: Aruchuna Ruban, Michael Glaysher, Alexander Miras, Christina G. Prechtl, Anthony P. Goldstone, Nicholas A. Johnson, Madhawi Aldhwayan, Navpreet Chhina, Werd Al-Najim, Hutan Ashrafian, Mayank Patel, James Byrne, Julian P. Teare Tags: Poster abstracts Source Type: research